Prestige Consumer Healthcare (NYSE:PBH) Price Target Raised to $100.00
Prestige Consumer Healthcare (NYSE:PBH – Free Report) had its price objective upped by Canaccord Genuity Group from $93.00 to $100.00 in a report issued on Friday morning,Benzinga reports. They currently have a buy rating on the stock. Other research analysts have also recently issued research reports about the stock. DA Davidson boosted their price target […]
![Prestige Consumer Healthcare (NYSE:PBH) Price Target Raised to $100.00](https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/prestige-consumer-healthcare-inc-logo.jpg?v=20221121160940&w=240&h=240&zc=2)